Testing superiority at interim analyses in a non‐inferiority trial
暂无分享,去创建一个
[1] C. Crumpacker,et al. Rapid and Durable Antiretroviral Effect of the HIV-1 Integrase Inhibitor Raltegravir as Part of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection: Results of a 48-Week Controlled Study , 2007, Journal of acquired immune deficiency syndromes.
[2] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[3] S. Ellenberg,et al. Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific Cases , 2000, Annals of Internal Medicine.
[4] Y Tsong,et al. Group sequential test strategies for superiority and non‐inferiority hypotheses in active controlled clinical trials , 2001, Statistics in medicine.
[5] Adriano Lazzarin,et al. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial , 2009, The Lancet.
[6] W. Brannath,et al. Sequential Tests for Noninferiority and Superiority , 2003, Biometrics.
[7] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[8] J. Haybittle,et al. Repeated assessment of results in clinical trials of cancer treatment. , 1971, The British journal of radiology.
[9] Milton C Weinstein,et al. Comparative effectiveness and health care spending--implications for reform. , 2010, The New England journal of medicine.
[10] B W Turnbull,et al. Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses. , 1993, Biometrics.
[11] Thomas H. Scheike. A boundary-crossing result for Brownian motion , 1992 .
[12] Tze Leung Lai,et al. Modified Haybittle–Peto group sequential designs for testing superiority and non‐inferiority hypotheses in clinical trials , 2006, Statistics in medicine.
[13] R. D'Agostino,et al. Non‐inferiority trials: design concepts and issues – the encounters of academic consultants in statistics , 2002, Statistics in medicine.
[14] W C Blackwelder,et al. "Proving the null hypothesis" in clinical trials. , 1981, Controlled clinical trials.
[15] Christopher Jennison,et al. Optimal group-sequential designs for simultaneous testing of superiority and non-inferiority. , 2010, Statistics in medicine.
[16] S. Yusuf,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[17] R. Simon,et al. Planning and monitoring of equivalence studies. , 1988, Biometrics.
[18] S S Ellenberg,et al. Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific Issues , 2000, Annals of Internal Medicine.
[19] G. Losonsky,et al. Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial , 2010, Pediatrics.
[20] H. I. Patel,et al. Multistage test procedure for testing Blackwelder's hypothesis of equivalence. , 1994, Journal of biopharmaceutical statistics.
[21] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[22] R. Gray,et al. Randomized clinical trial design for assessing noninferiority when superiority is expected. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] P. Armitage,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.
[24] D. Schoenfeld. The asymptotic properties of nonparametric tests for comparing survival distributions , 1981 .
[25] K Kim,et al. Sample size determination for group sequential clinical trials with immediate response. , 1992, Statistics in medicine.
[26] David Parkin,et al. NICE's cost effectiveness threshold , 2007, BMJ : British Medical Journal.
[27] T. Morikawa,et al. A useful testing strategy in phase III trials: combined test of superiority and test of equivalence. , 1995, Journal of biopharmaceutical statistics.